WT | News

Discover our incredible news!

News

X
Text dummy
Text Link

Healthtech Startup Ultrahuman Raises $17.5M In Series B Funding

Health technology startup Ultrahuman has raised $17.5 million in series B funding round backed ...

Health technology startup Ultrahuman has raised $17.5 million in a series B funding round backed by Alpha Wave Incubation (AWI), Steadview Capital, and existing backers Nexus Venture Partners, Blume Ventures, and Utsav Somani’s iSeed fund. Marquee founders and angel investors also participated including Tiger Global’s Scott Schleifer, Sandeep Singhal, Kunal Shah, Sujeet Kumar, Deepinder Goyal, Gunjan Patidar, Gaurav Munjal, Revant Bhate, Mohit Gupta, Vikram Dhingra, and Roman Saini.

Read more: Biomarker Technologies Market Expected To Grow At 12.4% Reaching Over US$ 117,853 Mn by 2027

The new funding brings the total funds raised so far to $25 million. The Bengaluru-based company is committed to making metabolic fitness accessible to millions of people globally. Ultrahuman said it will use the money to improve its biomarker technology and expand globally.

Ultrahuman was started by Mohit Kumar and Vatsal Singhal, who previously founded hyper-local logistics services provider Runnr. It merged with the food delivery app Zomato in 2017 and was a key acquisition for its food delivery aspirations.

Over a billion people in the world suffer from a metabolic health disorder, which contributes to 85 percent of all chronic diseases in the world, the company said in a statement.

“When we started Ultrahuman, we asked ourselves the question 'How does one eat and workout based on the specifics of their own body and their own goals?'. Given there's so much out there around 'what's an ideal diet' or the 'most effective exercise routine' — to figure out how fitness protocols such as eating healthy and exercising lead to better health in a quantifiable way seemed like a big confusing black box,” the company wrote in a statement.

“We wanted to change that by giving people access to a radical new approach—An approach that utilizes biomarkers to tell you how your body reacts to a certain type of food, how to fuel efficiently for exercise, and how to eat for better sleep. Our mission is to help people optimize their health by providing them access to deeply personalized insights and real-time nudges.”

The company’s product branded ‘Cyborg’ is a wearable and subscription service that helps people optimize their exercise and nutrition, based on glucose biomarkers.

Read more: Garmin-Lumen Partnership Launches Second Phase Integration With Metabolic Fitness Data

“Biomarkers will change how the fitness and the healthcare industry works. By being able to continuously monitor their biomarkers like glucose, users can not only avoid chronic diseases but make lifestyle changes that help them improve their fitness levels for longevity and performance,” said Mohit Kumar, founder and CEO, of Ultrahuman.

Text Link

Zeit’s Wearable Headband Detects Sleep Stroke Before They Occur

People at risk of strokes are always on the lookout for signs, but one cannot be alert whey they ...

People at risk of strokes are always on the lookout for signs, but one cannot be alert when they are sleeping. This means thousands of people suffer “wake-up strokes” that are only identified hours after they have occurred. Zeit Medical, a Redwood, CA-based company has developed a brain-monitoring smart headband that constantly monitors the electrical activity of your brain and gets help immediately. This could enable a stroke victim to get to the hospital fast enough to mitigate the stroke’s damage and potentially save lives.

Read more: Ultrasound Wearable Patch Could Provide Early Warning for Heart Attacks and Strokes

“Every minute a stroke goes untreated, two million brain cells are lost, resulting in even worsening disability. Immediate treatment can save brain cells from dying and help to restore brain function. Strokes can occur abruptly in any setting, but strokes are almost impossible to recognize during sleep, as most strokes do not cause pain,” the company says.

Zeit Medical’s device is designed to comfortably monitor the brain's electric activity while you sleep. If it detects a stroke, it will call pre-specified contacts or 911 for you. This will allow you to get treatment right away and finally sleep without anxiety about having a stroke at night.

Just like the presentation of arrhythmia on EKG, neurological injuries induce specific patterns in EEG. Zeit’s technology identifies these signature patterns immediately and enables fast diagnosis and treatment.

A few decades ago, not much could be done to help a stroke victim. In the 1990s, an effective drug came into use, and a little later, a surgical procedure was also introduced. However, both of these treatment required to be administered within a few hours after the onset of the stroke, reports TechCrunch. Orestis Vardoulis and Urs Naber decided to change that. The duo started Zeit, which means ‘time,’ to detect a stroke before it occurs.

“As soon as the stroke hits you, your brain begins to die, so time is of the essence. People have spent millions reducing the time between calling 911 and transportation, and from the hospital door to treatment. but nobody takes care of those hours that pass before the 911 call, so we realized that’s where we have to innovate,” Naber said.

Read more: iRhythm’s Zio Wearable Patch Detects Previously Undiagnosed Atrial Fibrillation, Prevents Stroke

“We hope to see a future where everyone with a stroke risk is issued this device,” Vardoulis told TechCrunch. “We really do see this as the missing puzzle piece in the stroke care continuum.”

Text Link

WHOOP Acquires Sports Tech Startup PUSH To Unlock Deeper Strength-Training Insights

WHOOP, the human performance company, announced the acquisition of PUSH, a Toronto-based sports ...

WHOOP, the human performance company, announced the acquisition of PUSH, a Toronto-based sports technology startup in a cash and stock transaction. The two wearable technology companies are built on a similar foundation of sports science and physiological research with a shared focus on delivering personalized data, actionable insights, and demonstrable health improvements.

Read more: Golf Fans Can See Players’ Heart Rates Thanks to New Partnership with Whoop

PUSH focuses on velocity-based training data with a sensor that can live in multiple locations on the body to help quantify weightlifting performance via metrics like speed, power, force, and acceleration. PUSH works with hundreds of organizations and sports teams around the world, serving collegiate, professional, and Olympic athletes as well as elite military teams.

“Many of the members and organizations we serve have long asked for additional insight into the physiological impact of weightlifting and functional fitness,” said Will Ahmed, WHOOP Founder and CEO. “The integration of PUSH’s industry-leading strength-training technology into our platform will allow WHOOP to provide even deeper insight into how these activities impact the human body.”

Studies show that WHOOP can positively impact behavior and promote meaningful lifestyle changes through 24/7 continuous heart rate monitoring coupled with insights across sleep, recovery, and strain. With the acquisition of PUSH, the WHOOP platform will be equipped with a more enhanced and robust system of hardware, software, and analytics that provide comprehensive feedback on training activities and wellness, according to a press release.

“Our team has been dedicated to creating cutting-edge technology solutions to help athletes at all levels reach their goals and push human performance forward,” said Rami Alhamad, PUSH Founder and Chief Product Officer. “We are thrilled to join WHOOP and offer our customers a more complete picture of their training.”

WHOOP provides unparalleled insights for improved performance and health to members, government agencies and military teams, professional sports leagues and teams, and numerous other organizations. WHOOP is the Official Fitness Wearable of the PGA TOUR and LPGA Tour, the Official Wearable of CrossFit, and the Official Recovery Wearable of the NFLPA.

About WHOOP

WHOOP provides 24/7 coaching to improve fitness and health. WHOOP members benefit from hardware, a coaching platform designed to optimize behavior, and a community of high performers. WHOOP serves organizations and individuals including professional athletes, Fortune 500 CEOs, fitness enthusiasts, military personnel, frontline workers, and anyone looking to improve their performance.

Read more: How Wearables Like Oura and Whoop Became Pandemic Lifestyle

About PUSH

PUSH maximizes human performance through technology. The PUSH system empowers coaches and trainers to plan, track, assess and improve athlete performance in real-time. The PUSH system consists of a PUSH Band (wearable accelerometer), a Portal, a training management system that coaches use to plan full workout programs and an app that provides athletes with access to programs in the weight room or remotely. PUSH supports coaches and athletes across many sports and levels.

Text Link

Biofourmis Receives FDA Breakthrough Device Designation for Novel Digital Therapeutic for Heart Failure

Boston-based virtual care provider Biofourmis dreams of a future where heart failure patients ...

Boston-based virtual care provider Biofourmis dreams of a future where heart failure patients will stay home where they will be remotely monitored via a wearable sensor and an app. The company has now come one step closer to that goal. The FDA for the first time gave the company’s BiovitalsHF® solution a Breakthrough Device designation. BiovitalsHF is a software medical application that augments guideline-directed use of heart failure medications to manage patients in combination with traditional pharmacotherapy.

Read more: Biofourmis Raises $100 Million In Series C Funding To Accelerate Global Expansion

“This important breakthrough designation will help accelerate FDA's final review of BiovitalsHF,” said Kuldeep Singh Rajput, CEO and founder of Biofourmis. “If approved at the end of this expedited process, we look forward to introducing a new virtual heart failure care model that leverages the BiovitalsHF digital therapeutic to improve the use and dosing of Guideline-Directed Medical Therapy among patients with heart failure, for better patient outcomes and reduced healthcare expenditures.”

Heart failure remains the leading cause of hospitalization for patients over age 65. In the U.S., approximately 6.2 million patients live with heart failure, which carries an annual cost that is expected to reach $70 billion by 2030. Guideline-Directed Medical Therapy (GDMT) is a cornerstone of the management of individuals with heart failure with reduced ejection fraction (HFrEF). Timely initiation and dose intensifications of GDMT continue to be a major challenge in realizing clinical trial outcomes in the real world, despite the availability of guidelines from professional societies such as the American Heart Association and the American College of Cardiology, according to a press release.

BiovitalsHF augments clinical decision-making with the goal of personalizing and improving the use and dose of GDMT among patients with HFrEF. The device integrates physiological monitoring, symptoms, signs reporting, patient engagement, medication management, and communication to provide clinicians with personalized and specific medication recommendations. The system alleviates some of the problems that prevent GDMT titration because a) it enables patient health status and drug tolerance to be accurately assessed through continuous physiology monitoring and inclusion of lab assessment results for analysis; b) it reduces clinical inertia by prompting clinicians and patients on medication initiation and up-titration; c) it reduces the burden of clinical visits through a patient-clinician communication system, which becomes essential in circumstances such as a pandemic; and d) it requires fewer resources than nurse-led programs because titration recommendations from the HFrEF management guidelines are distilled in the system.

"The BiovitalsHF digital therapeutic is a software medical application that enables providers to rapidly initiate and intensify life-saving and guideline-recommended medical therapies for patients with heart failure with reduced ejection fraction in a way that is nearly automated," said Maulik Majmudar, MD, cardiologist and chief medical officer and co-founder of Biofourmis. "In a proof-of-concept study, in patients using BiovitalsHF, we demonstrated statistically significant improvements in adherence to GDMT; reduction in levels of the key blood biomarker of heart failure NT-ProBNP; and improvements in health status.”

Read more: Chugai and Biofourmis Collaborating to Develop Digital Solution For Objective Assessment of Pain

Dr. Majmudar added: "BiovitalsHF gets patients on the right therapies faster, which studies have shown helps save lives, prevents emergency department visits and hospital admissions, and enables patients to have a better quality of life. The FDA Breakthrough Devices program was created to help bring the effective treatment of life-threatening or irreversibly debilitating conditions to market sooner, and BiovitalsHF is a perfect candidate for this program due to its clinical importance and impact.”

Text Link

Vivalink Launches End-to-end Biometrics Data Platform For Remote Patient Monitoring and Clinical Trials

Vivalink, a specialist in virtual care and digital clinical trials, announced the launch of its ...

Vivalink, a specialist in virtual care and digital clinical trials, announced the launch of its enhanced Biometrics Data Platform to accelerate the development and deployment of patient monitoring and data analysis applications for ambulatory and remote settings. Vivalink's Biometrics Data Platform completes the company's end-to-end solution that includes both advanced data services as well as medical wearable sensors.

Read more: Vivalink’s Wearable ECG Monitor Can Now Be Used for 6-Minute Walk Test

As the first real-world evidence data platform of its kind, Vivalink's integrated Biometrics Data Platform is available as a data and insights service platform for digital healthcare solution providers serving the virtual care and drug development markets. The platform is able to accelerate time-to-market by removing the development and regulatory complexities associated with wearable sensors, edge networks, data integration, and data analytics, according to a press release.

The Biometrics Data Platform combines Vivalink's best-in-class medical wearable sensors for continuous and episodic data capture, a clinical patient mobile app, advanced data processing, and machine learning technologies. It's able to automatically collect a continuous stream of vital signs and biometrics in real-world settings such as when the patient is at home or ambulatory and ensures data is delivered successfully from any location for centralized analysis and processing in order to extract clinically relevant insights in real-time or retrospectively.

The patient-friendly sensors integrated into the platform have obtained regulatory clearance in major geographic regions including the USA, EU, and China. Vivalink offers the largest range of reusable sensors for human vital sign monitoring, with recently updated temperature and multi-vital cardiac ECG sensors that have improved usability with an extended data cache, improved battery life, and stronger network connectivity. Such improvements were made based on their years of experience in real-world patient applications. The Vivalink data platform adheres to HIPAA and GDPR and is developed per FDA Design Controls, ISO 13485, IEC 62304, and ISO 14971.

Key features of the Biometrics Data Platform include:

  • Wide range of patient-friendly medical wearable sensors for automated continuous data capture of human vital signs and key metrics
  • Remote data transfer and synchronization technologies to ensure data ingestion and delivery
  • Live and retrospective data access, with raw and filtered data, supported by an advanced biometric data lake for machine learning and AI
  • Automated data transformation for clinical database ingestion
  • Cloud-based regulatory-cleared, advanced algorithms including automated arrhythmia detection and reporting to generate real-time insights
  • Data integration, complete with FHIR support, web services APIs, Webhook support
  • Data visualization tools
  • Complete systems management of sessions, sensors, and more

Related Vivalink Launches New Turnkey Service for Healthcare Applications in Remote Patient Monitoring

Vivalink (Formerly VivaLNK) has experienced strong adoption of its platform in ambulatory cardiac monitoring, virtual care, and decentralized clinical trials. More than 100 digital healthcare solution partners and customers in 25 countries are delivering a wide range of medical applications based on this platform.

Text Link

Apple Reportedly Looking to Add Blood Pressure Monitoring and Fertility Tracking In Smartwatch

Apple’s next watch may have blood pressure monitoring and a thermometer to help with fertility ...

Apple’s next watch may have blood pressure monitoring and a thermometer to help with fertility planning, according to a report by Wall Street Journal.

Read more: The Next Apple Watch May Have A Totally Redesigned Wrap-Around Display

While these features appear to be in the not-so-distant future, the documents reveal that the tech giant has broader ambitions for its smartwatch. The future Apple smartwatches may have the ability to detect sleep apnea, provide medical guidance when it senses low blood oxygen levels, and, perhaps one day, spot diabetes, according to the WSJ article.

According to the report, Apple wants to develop a sensor that can function as a proxy for a blood pressure cuff without squeezing the wrist. The company has been working for a long time on this feature.

If these plans come to fruition, this represents another step in Apple’s healthcare. The Cupertino-based tech giant made headlines in 2018 when it won FDA De Novo approval for its smartwatch with an ECG reader.

Since then, the company has continued to add health features to its smartwatches. In December, MobiHealth reported that Apple was adding a VO2 Max feature on its smartwatches, as well as a new ECG feature that detects Atrial Fibrillation.

Apple’s foray into the femtech space isn’t new. Apple partnered up with Harvard University’s TH Chan School of Public Health on the Apple Women’s Health Study, which aims to understand more about periods in women across demographics and lifestyles.

Other wearables manufacturers are also working on these features. For example, Fitbit added a skin temperature and an FDA-cleared ECG app that detects AFib on the company’s Sense smartwatches.

Read more: Apple Watch Accurately Predicts Frailty in Patients With Cardiovascular Disease

Fitbit is also studying its smartwatches’ ability to measure blood pressure using pulse arrival time, which measures how long it takes for blood to reach a person’s wrist after their heartbeats.

Samsung is another company trying out health features on its smartwatches. Samsung is using an optical heart rate sensor for blood pressure monitoring.

Text Link

13th IoT/WT Innovation World Cup Success Story – Articulate Labs

Articulate Labs – an innovative start-up from Dallas, Texas, won the AiQ Smart Clothing Challenge...

Articulate Labs – an innovative start-up from Dallas, Texas, won the AiQ Smart Clothing Challenge at the 13th IOT/WT Innovation World Cup. Articulate Labs has developed wearable technology that turns the everyday activity into on-the-go physical therapy and rehabilitation through muscle stimulation and machine learning.

  1. INTRODUCE YOURSELF! – HOW DID IT ALL START?

My co-founder, Herbie Kirn, started to develop KneeStim to help manage his own rehabilitation. He lost his right leg in a motorcycle accident over fifteen years ago and quickly wore down the cartilage in the knee of the fully intact leg as he relearned to walk. Told he was too young for knee replacement, but he was advised to go through all of the conservative options available and found braces, injections, and medications each to have unacceptable drawbacks or side effects. What did work for him was physical therapy, with an emphasis on quadriceps strengthening, but didn’t have time for all of the rehabs he needed without impacting work and family responsibilities. While at PT, he was using a neuromuscular electrical stimulation unit while doing leg lifts and started wondering why this process wasn’t more fully automated. What has resulted from quite a bit of trial-and-error in form factor and operating system development is a platform technology that we believe will address unmet knee joint rehabilitation needs for millions and later a multitude of musculoskeletal disorders and a new class of medical devices.

Read more: 13th IoT/WT Innovation World Cup Success Story – PK vitality

  1. WHAT ARE THE KEY MILESTONES YOU HAVE REACHED SO FAR?

To date, we have completed a manufacturable/3D-printable version of our device, have earned two letters of interest from hospital systems in Texas, have two paid pilots pending in other countries, have five utility patents granted in the US plus one core patent being nationalized in key European countries. We’ve done all of the above with what’s been largely a two-person team and a (for medical devices) shoestring budget considering we’ve never earned non-dilutive grant funding for research.

  1. WHAT WERE THE BIGGEST CHALLENGES YOU HAVE FACED?

I don’t have formal education in business, engineering, or medicine and didn’t feel qualified to serve in this role for a long time. My co-founder had no previous experience with biomechanics or the development of hardware or software to medical technology standards. We both have had to supplement our knowledge and experience with experts in those particular fields and have benefitted greatly from those relationships. Every start-up will be in this situation because there’s no way your initial team, no matter how big or experienced, can have all of the answers instantly. If I had to start this all over again, though, I would do a better job creating value for our advisors and consultants rather than just feeling guilty about asking for help, and I would be more respectfully critical of their work instead of accepting it without question.

  1. WHAT IS COMING IN THE NEAR FUTURE?

The next big steps are earning regulatory clearance for our device for sale in the US and abroad, launching our validation studies, and starting to offer our devices to patients. We’re currently building out the We also want to move from what we’re considering an MVP version of our device to something that is lighter and leaner.

  1. DESCRIBE YOUR EXPERIENCE IN THE INNOVATION WORLD CUP® AND STANDING AMONGST THE TOP15 WEARABLE AND EBV IOT HERO INNOVATORS 2021?

I felt that the WT/IoT conference was very well organized and that the sessions did a great job addressing challenges unique to the wearable industry. I came away with several relationships that I believe will benefit now with our knee-focused device and in the future as we expand to other joints and conditions. I’m certainly looking forward to participating in future WT/IoT conferences and seeing who we meet next.

  1. CAN YOU SHARE WITH US YOUR THREE TIPS FOR UPCOMING START-UPS?

Share your passion – I think part of what distinguishes our company and our work is that it started with a deeply personal unmet need that genuinely couldn’t be addressed by existing means. Our work began to resonate much more with people when we stopped being ashamed of the fact that this device was initially prototyped in an apartment living room with a makeshift machine shop next to a sofa. It’s what helps gives others the confidence that you’ll find a way to push through and solve the problems that your company will inevitably face as it grows.

Practice your presentation – A saying that’s always stuck with me is “We don’t rise to the level of our expectations; we fall to the level of our training.” In the case of pitching, this means putting in the work – figuring out concise answers to questions, creating logical transitions from section to section, committing particular phrases to memory – so that you feel confident and relaxed talking about your company for 30 seconds or 30 minutes no matter what the circumstances.

Read more: Stryker Buys OrthoSensor and Its Knee Surgery Sensor Technology Verasense

Make relationships the goal, not the prize – We started doing better at these events when I started focusing on what we can take away from an event regardless of where we place after a three-minute presentation. In that regard, while we’re proud to have AiQ’s Smart Clothing prize, the real goal was to earn an opportunity to work on a long-term basis with Nadia, Satya, and Steven at AiQ. Their involvement and materials could really help improve both our current knee treatment device and future applications of our core technology to other rehabilitation challenges throughout the body.

THANK YOU FOR THE INTERESTING INSIGHTS AND WE SHALL KEEP WATCHING YOUR NEXT BIG STEPS!

Visit Articulate Labs and learn more about their KNEESTIM- a light and form-fitting device that patients can use for muscle strengthening and re-education at home while they go about their normal day-to-day activities.

Join the Smart Clothing Challenge. Submit your solution free of charge. The top selected finalists will be invited to present their solutions live at HANNOVER MESSE 2022.

Don´t miss your chance!

Text Link

Scientists Develop Ingestible Robot That Delivers Insulin Without The Need For External Needles

Anytime the dispenses need to be refilled, the user takes one of the pills. The pill then ...

Anytime the dispenses need to be refilled, the user takes one of the pills. The pill then travels down their digestive system until it reaches the point where the device is implanted near their small intestine. The device then uses the power of magnets to rotate the capsule into position and then punctures it with a retractable needle and pumps the refill of insulin into a reservoir, reports EndGadget.

One of the most convenient things about this system is that the dispenser charges wirelessly, limiting the number of interventions a doctor needs to maintain the device. Once the capsule is empty, it continues its travel down the digestive system until the user releases it with his stool.

Read more: This Coin-Sized Smart Patch Delivers Insulin as Blood Sugar Increases

The researchers tested their device on three diabetic pigs. They found the system could successfully manage their insulin levels for several hours. In some instances, they found bodily fluids from the pigs would leak into the robot. So as a next step, the team is working on sealing the device better.

Text Link

Tiny Wireless Battery-Free Implant for Optogenetics Illuminates Neuron Activity in the Brain

Everything that happens in the brain is a result of neurons sending and receiving signals in ...

Everything that happens in the brain is a result of neurons sending and receiving signals in complex networks that are not completely understood by scientists. These networks are what allow us to pick up a cup of coffee, laugh at a joke or stand up from a chair. When some neurons do not send and receive signals properly, it can lead to problems such as epilepsy, depression, addiction, and chronic pain.

Read more: Innovative Brain Implant Reads and Stimulates Brain to Improve Parkinson’s Treatment

University of Arizona engineering researchers, led by biomedical engineering professor and Craig M. Berge Faculty Fellow Philipp Gutruf, are creating new tools for a method called optogenetics, which shines light at specific neurons in the brain to excite or suppress activity.

Optogenetics experiments are aimed at increasing understanding of how the brain works, allowing scientists to develop and test potential cures for illnesses such as neurodegenerative diseases, reports Emily Dieckman in the University of Arizona News.

In a new paper published in PNAS, UArizona researchers collaborated with researchers at Northwestern University to demonstrate an untethered light delivery tool to enable seamless optogenetics in the brain.

While this technique has huge potential to treat diseases on a neurological basis, the invasive nature of the current methodology is a major stumbling block. The light source developed at the University of Arizona aims to change that, and bring us a little closer to clinical optogenetics.

“This technique means we can use optogenetics without having to penetrate the skull or brain tissue, making it much less invasive,” said Jokubas Ausra, a biomedical engineering doctoral student in the Gutruf Lab and the first author of the paper.

Tiny Device, Big Results

In the new paper, Gutruf and his team report on the first wireless transcranial optogenetic simulation device that can send light through the skull rather than physically penetrating the blood-brain barrier. The transcranial technique is done using a wireless and battery-free device that's as thin as a sheet of paper and about half the diameter of a dime, implanted just under the skin.

“This is significant because when optogenetics become available for humans, we have technology that enables seamless light delivery to neurons in the brain or spine,” said Gutruf, who is also a member of the university's BIO5 Institute. “This means we have a precursor technology that could someday help manage conditions like epilepsy or chronic pain without invasive surgery and chronic use of drugs.”

Read more Wise Therapeutics and Soterix Announce Results of Their Collaborative Study Combining Digital Therapy With Neurostimulation Device

Speeding Up Future Progress

There is still a long way to go before the technology is available to humans. In particular, progress must be made on methods for introducing light-sensitive proteins into the human brain and periphery.

“This tool allows scientists to do a wide range of experiments that were previously not possible,” Gutruf said. “These possibilities enable the scientific community to make faster progress to uncover the working principles of the brain and develop and test treatments in accurate environments. This is important for many areas – for example, enabling drug-free pain therapies to beat the opioid crisis.”

Text Link

LifeProof Creates Eco-Friendly Cases for Apple Products Using Ocean-Based Recycled Plastics

LifeProof, a San Diego-based mobile phone cases and accessories maker, is making eco-friendly ...

LifeProof, a San Diego-based mobile phone cases and accessories maker, is making eco-friendly cases for Apple Watch, AirPods, and AirPods Pro and Eco-Friendly Band for Apple Watch, using ocean-based recycled plastic. In just over a year, more than 37,500 pounds of ocean-based plastic have been repurposed into LifeProof cases.

Read more: Apple Watch’s Future Band Design Could Boost Battery Life

"LifeProof was born from the ocean with waterproof cases, and it is our responsibility to protect those waters that are so dear to us," said Jim Parke, LifeProof CEO.  "These new designs align with everything that we stand for – uncompromised protection and a dedication to help preserve our ocean by building cases from ocean-based recycled plastic.”

Dive into sustainable style with the latest LifeProof accessories for Apple Watch, Apple AirPods, and Apple AirPods Pro, says a press release.

Synchronize your high-tech timepiece to Pacific Sustainability Time with the Eco-Friendly Case for Apple Watch 4/5/6/SE 40mm and 44mm. It delivers a form-fitting line of defense for the display and edges and is made with 85 percent ocean-based recycled plastic. Health monitors, activity trackers, dials, and buttons – everything you love about your watch works just the same with the case.

Combine protection with a sustainable band for the perfect duo. Slip into something more comfortable and sustainable with the LifeProof Band for Apple Watch 38/40 mm. Made from 99 percent ocean plastic yarn, it's easy on the environment and feels good on your wrist all day long. It pairs seamlessly with your watch, connects with a buckle closure, and resists both wear and fading.

Keep your charging case safe from calamities with the Eco-Friendly Case for Apple AirPods and Eco-Friendly Case for Apple AirPods Pro. Built from 75 percent ocean-based recycled plastic, each case delivers edge-to-edge protection. Outfitted with a quick clip carabiner, it's easy to attach to a bag or keyring.

Read more: PlusUs Introduces First-Ever Flexible Wireless Charging Pad Made of Eco-Friendly Materials

In line with its corporate mission of giving back, LifeProof is inviting its consumers to make a difference, too. In partnership with Water.org, Coral Reef Alliance, American Rivers, and Oceana, LifeProof will donate for every registered purchase to support a healthier future for our world's water.

Eco-Friendly cases for Apple Watch, LifeProof Band, and cases for Apple AirPods and Apple AirPods Pro are available now on the lifeproof website.

Text Link

Finnish Researchers Develop Wearable Device to Assess Myoclonic Jerks

Researchers at the University of Eastern Finland and Kuopio University Hospital have developed a ...

Researchers at the University of Eastern Finland and Kuopio University Hospital have developed a wearable device that can measure the occurrence and severity of myoclonic jerks, which are sudden muscle movements experienced by patients with progressive myoclonic epilepsy.

Read more: ULTEEM: Noninvasive Epilepsy Monitoring Wearable That Attaches To Any Ordinary Eyeglasses

The method used in the study was based on the measurement of electrical neuromuscular function and movement, and it corresponded well to an assessment performed by an experienced physician. The findings were recently published in Clinical Neurophysiology.

Patients with progressive myoclonic epilepsy (EPM1) suffer from myoclonus, i.e., sudden muscle jerks that are activated by movement and other stimuli. The severity of these myoclonic jerks varies during the day, and myoclonus can be either positive or negative. A positive myoclonus refers to a sudden contraction of a muscle, while negative myoclonus refers to loss of muscle activation, which in a worst-case scenario may lead to the fall of a patient, for example.

The aim of this study was to develop and test a wearable technology-based method for assessing myoclonus symptoms in the home environment. Patients wore a small, wearable sensor on their arms for 48 hours, which measured their muscle function and movement. They also wrote down their own assessment of the severity of the myoclonus symptom. An algorithm that picks up the occurrence and variation of muscle jerks from the measurement data was developed to evaluate myoclonus symptoms, describing them as a myoclonus index, reports the University of Eastern Finland.

In current clinical practice, the Unified Myoclonus Rating Scale, UMRS, is used to assess myoclonus symptoms. When using the UMRS, an experienced physician views a video recording and scores the patient’s symptoms according to their severity. This UMRS assessment provides information on the occurrence of myoclonus at one point in time. The measurement-based myoclonus index developed in the study correlated well with the UMRS assessment performed by the physician. Patients’ at-home measurements showed that the measurement-based myoclonus index was able to detect variation in the occurrence of myoclonus symptoms during the day and night. The reliability of the measurement results was also supported by patients’ own, at-home assessments and reporting of their myoclonus symptoms.

According to the study, the myoclonus index can be used to reliably assess positive and negative myoclonus in patients with EPM1. This assessment correlates well with the assessment performed by an experienced physician, and also makes it possible to assess patients’ symptoms in the home environment.

Read more: CyMedica Launches Clinical Trial to Evaluate the Effectiveness of its Muscle Strengthening Device e-vive

The study was carried out as part of the larger New Modalities ecosystem funded by Business Finland, involving three universities and eight companies in Finland. The ecosystem is coordinated by Orion Corporation.

Text Link

NeuroPace Develops Smart Wearable RNS System For The Treatment of Drug-Resistant Epilepsy

Epilepsy is a central nervous system (neurological) disorder in which brain activity becomes ...

Epilepsy is a central nervous system (neurological) disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behavior, sensations, and sometimes loss of awareness.

Read more: Purdue Researchers Develop Wearable That May Help Prevent Sudden Death From Epilepsy

Treatments include:

  • Anti-epileptic drugs (AEDs)
  • Surgery to remove a small part of the brain that's causing the seizures
  • A procedure to put a small electrical device inside the body that can help control seizures
  • A special diet (ketogenic diet) that can help control seizures

Drug-resistant epilepsy, also known as intractable epilepsy or refractory epilepsy, is defined as the failure of at least two anti-seizure drugs.

NeuroPace, a California-based MedTech company has developed the RNS system, an implantable neuromodulation device for treating drug-resistant epilepsy. It is the only FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity and provides EEG data that can help improve patient care, reports NuroPace.

“The RNS System’s brain-responsive platform delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients suffering from drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders,” Martha Morrell, Chief Medical Officer at NeuroPace, told Medgadget’s Conn Hastings.

The RNS System opens new possibilities for adults with focal drug-resistant epilepsy. The device responds to your unique brain activity and gives your doctor valuable information to help personalize your epilepsy treatment.

Read more: Medtronic to Launch Deep Brain Simulation for Medically-Refractory Epilepsy in the U.S.

Benefits of the RNS system:

Fewer seizures. In a real-world study, RNS System patients reported experiencing fewer seizures.

Lower SUDEP rate. SUDEP is the sudden, unexpected death of someone with epilepsy, who was otherwise healthy.

Improved health and wellness. In a clinical study of the RNS System, patients reported significant quality of life improvements.

Text Link

MIT Researchers Develop Touch-Sensing Glove That May Help In Stroke Recovery

When you pick up a balloon, the pressure to keep hold of it is different from what you would ...

When you pick up a balloon, the pressure to keep hold of it is different from what you would exert to grasp a jar. And now engineers at MIT and elsewhere have a way to precisely measure and map such subtleties of tactile dexterity.

Read more: Thermal Display Glove Enable Users to Feel Virtual Temperatures in Real-Time

The team has designed a new touch-sensing glove that can “feel” pressure and other tactile stimuli. The inside of the glove is threaded with a system of sensors that detects, measures, and maps small changes in pressure across the glove. The individual sensors are highly attuned and can pick up very weak vibrations across the skin, such as from a person’s pulse.

When subjects wore the glove while picking up a balloon versus a beaker, the sensors generated pressure maps specific to each task. Holding a balloon produced a relatively even pressure signal across the entire palm while grasping a beaker created stronger pressure at the fingertips.

The researchers say the tactile glove could help to retrain motor function and coordination in people who have suffered a stroke or other fine motor conditions. The glove might also be adapted to augment virtual reality and gaming experiences. The team envisions integrating the pressure sensors not only into tactile gloves but also into flexible adhesives to track pulse, blood pressure, and other vital signs more accurately than smart watches and other wearable monitors, reports Jennifer Chu in MIT News.

“The simplicity and reliability of our sensing structure hold great promise for a diversity of health care applications, such as pulse detection and recovering the sensory capability in patients with tactile dysfunction,” says Nicholas Fang, professor of mechanical engineering at MIT.

Fang and his collaborators detail their results in a study in Nature Communications. The study’s co-authors include Huifeng Du and Liu Wang at MIT, along with professor Chuanfei Guo’s group at the Southern University of Science and Technology (SUSTech) in China.

The glove’s pressure sensors are similar in principle to sensors that measure humidity. the team fabricated thin, kernel-sized sensing electrodes lined with thousands of gold microscopic filaments, or “micropillars.” They demonstrated that they could accurately measure the degree to which groups of micropillars bent in response to various forces and pressures. When they placed a sensing electrode and a control electrode onto a volunteer’s fingertip, they found the structure was highly sensitive. The sensors were able to pick up subtle phases in the person’s pulse, such as different peaks in the same cycle. They could also keep up accurate pulse readings, even as the person wearing the sensors waved their hands as they walked across a room.

“Pulse is a mechanical vibration that can also cause deformation of the skin, which we can’t feel, but the pillars can pick up,” Fang says.

The researchers then applied the concepts of their new, micropillared pressure sensor to the design of a highly sensitive tactile glove. They started with a silk glove, which the team purchased off the shelf. To make pressure sensors, they cut out small squares from carbon cloth, a textile that is composed of many thin filaments similar to micropillars.

They turned each cloth square into a sensing electrode by spraying it with gold, a naturally conductive metal. They then glued the cloth electrodes to various parts of the glove’s inner lining, including the fingertips and palms, and threaded conductive fibers throughout the glove to connect each electrode to the glove’s wrist, where the researchers glued a control electrode.

Several volunteers took turns wearing the tactile glove and performing various tasks, including holding a balloon and gripping a glass beaker. The team collected readings from each sensor to create a pressure map across the glove during each task. The maps revealed distinct and detailed patterns of pressure generated during each task.

The team plans to use the glove to identify pressure patterns for other tasks, such as writing with a pen and handling other household objects. Ultimately, they envision such tactile aids could help patients with motor dysfunction to calibrate and strengthen their hand dexterity and grip.

Read more: NeoMano Robotic Glove Helps People with Paralyzed Hands to Grip Objects

“Some fine motor skills require not only knowing how to handle objects but also how much force should be exerted,” Fang says. “This glove could provide us more accurate measurements of gripping force for control groups versus patients recovering from stroke or other neurological conditions. This could increase our understanding, and enable control.”

Text Link

Renesas Partners with Syntiant To Develop Voice-Controlled Multimodal AI Solution

Semiconductor maker Renesas is partnering with deep learning chip technology firm Syntiant to ...

Semiconductor maker Renesas is partnering with deep learning chip technology firm Syntiant to develop a voice-controlled multimodal AI solution that enables low-power contactless operation for image processing in vision AI-based IoT and edge systems, such as self-checkout machines, security cameras, and video conference systems, and smart appliances such as robotic cleaning devices.

Read more: Renesas Launches RE Family – Energy Harvesting Embedded Controllers

The new solution combines the Renesas RZ/V Series vision AI microprocessor unit (MPU) and the low-power multimodal, multi-feature Syntiant NDP120 Neural Decision Processor to deliver advanced voice and image processing capabilities. The joint solution features always-on functionality with quick voice-triggered activation from standby mode to perform object recognition, facial recognition, and other vision-based tasks that are critical functions in security cameras and other systems. For example, while user-defined voice cues drive activation and system operation, vision AI recognition tracks operator behavior and controls operation or issues a warning when suspicious actions are detected.

The multimodal architecture makes it easier to create contactless user experiences for vision AI-based systems. Using a dedicated, power-efficient chip for voice recognition reduces standby power consumption while speeding up system development because it is possible to develop software independently of the vision AI functionality, reports Renesas.

“We anticipate that demand for multimodal systems that use multiple streams of input information – both image and voice – will increase moving forward as a way to improve both ease of use and safety,” said Hiroto Nitta, Senior Vice President and Head of SoC Business in the IoT and Infrastructure Business Unit at Renesas. “Through the collaboration between Renesas, a leader in low-power image AI technology, and Syntiant, a leader in voice AI technology, we will accelerate the adoption of low-power, ultra-small smart voice AI technology in embedded systems and deliver new combined solutions to customers globally.”

“Voice-based user interfaces will make it possible for customers to deliver new user experiences that bring the next generation of innovative ideas from concept to reality, said Syntiant CEO Kurt Busch. “We’ve already shipped more than 15 million of our deep learning NDPs globally to enable always-on voice in a wide variety of consumer and industrial IoT applications. Our collaboration with Renesas delivers a powerful, low-power voice and image solution that is certain to accelerate traction among a global customer base in a variety of devices and use cases.”

The Renesas RZ/V Series MPU for vision AI incorporates Renesas’ exclusive DRP-AI (Dynamically Reconfigurable Processor-AI) accelerator and combines high-precision AI inference with a power efficiency that is among the best in the industry. This superior power performance eliminates the need for heat dispersion measures such as heat sinks or cooling fans, which reduces the bill of materials (BOM) cost and makes it possible to integrate vision AI into a wide range of embedded applications.

The Syntiant NDP120 chip incorporates sophisticated AI capabilities that can be used to implement many high-precision, hands-free voice functions, including speaker recognition, keyword detection, multiple wake words, and local command recognition. Packaged with the Syntiant Core 2 neural network inference engine, the NDP120 can also run multiple applications simultaneously while minimizing power consumption to 1mW battery power.

Read more: Will Combined Power of 5G and Artificial Intelligence Change Tech Innovations of Tomorrow?

The new voice-controlled multimodal AI solution uses multiple mutually compatible devices from the broader Renesas portfolio to provide customers an elevated prototyping platform for faster time to market and reduced risk. The new solution is part of Renesas’ Winning Combinations, which feature compelling analog, power, and embedded processing product combinations that help customers accelerate their designs and get to market faster.

Availability

The reference design for the new multimodal AI solution is available now, including circuit diagrams and BOM lists.

Text Link

Nielsen to Start Placing PPM Wearables To Modernize and Improve Panelist Experience

Nielsen today announced that starting in September 2021, it will begin placing approximately ...

Nielsen today announced that starting in September 2021, it will begin placing approximately 3,000 new Portable People Meter (PPM) Wearables in a subset of its nearly 60,000 active PPM panelists. The deployment of PPM wearable devices and technologies is part of Nielsen's continued efforts to modernize its panels and improve the panelist experience, drive broader adoption among existing and new panelists, and increase engagement among more challenging demographics.

Read more: DIGISEQ’s New Solution Allows Consumers To Turn Any Wearable Into A Contactless Payment Device

The PPM is currently used to underpin Audio, Local TV, and National audience measurement. It is used to measure both in-home and out-of-home tuning for Audio and Local TV and out-of-home tuning for Nielsen's National TV estimates. The next-gen wearable PPM metering will serve as foundational support for Nielsen ONE, a cross-media solution that will deliver a single, deduplicated metric for total media consumption across TV, Digital, and Audio.

PPM Wearables feature an updated design that is smaller and more aligned with current wearable technology trends. The new PPM Wearable comes in a variety of ways to wear including wristbands, clips and pendants, which are more appealing among demographics that typically have lower compliance. In addition, a new companion app will help improve communication, encourage participation and enable data transmission when the device is outside the home. The companion app will also allow Nielsen to add new features and capabilities and adapt more seamlessly to new data and technology trends, according to a press release.

“By modernizing our panels with the PPM Wearable, we are not only improving the overall panelist experience and increasing engagement, but also ensuring our measurement is durable and can adapt to evolving technology changes,” said Mainak Mazumdar, Nielsen's Chief Research and Data Officer. “This is another example of how Nielsen is continuing to innovate in our march towards Nielsen ONE in order to create a better media future for the entire industry.”

Nielsen plans to share top-line findings in Q2 2022 of this subset of panelists phase, with the full rollout of PPM Wearables in new panel households planned for the second half of 2022. PPM Wearables have been through a series of rigorous tests and the system has performed very well in each phase. These tests included lab, focus groups, and dual-carry testing that measure how the wearables detect codes versus the current PPM among the same panelists.

PPM Wearables are part of Nielsen's ongoing commitment to innovation that enhances the quality of their panels and makes cross-platform measurement a reality in an increasingly fragmented media landscape.

Read more: Validic’s High Frequency Data Support Will Enable Wearables to Deliver Minute-to-Minute Readings

About Nielsen

Nielsen Holdings plc is a leading global data and analytics company that provides a holistic and objective understanding of the media industry. With offerings spanning audience measurement, audience outcomes, and content, Nielsen offers its clients and partners simple solutions to complex questions and optimizes the value of their investments and growth strategies. It is the only company that can offer de-duplicated cross-media audience measurement. Audience is Everything™ to Nielsen and its clients, and Nielsen is committed to ensuring that every voice counts.

Text Link

Synchron Receives FDA Clearance To Start Clinical Trial On Wearable That Helps Paralyzed People to Communicate

Synchron, a venture-backed brain data transfer company, today announced that the U.S. Food and ...

Synchron, a venture-backed brain data transfer company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for its flagship product, the Stentrode motor neuroprosthesis. This early feasibility study (EFS) of the device will begin later this year at Mount Sinai Hospital, New York, and will assess the safety and efficacy of patients with severe paralysis. Outcomes will include the use of brain data to control digital devices and achieve improvements in functional independence. The FDA granted Breakthrough Device designation to Synchron in August 2020.

Read more: Brain Computer Interface with Neurofeedback Can Improve Your Performance, Says Columbia Study

“The approval of this IDE reflects years of safety testing performed in conjunction with FDA. We have worked together to pave a pathway forward, toward the first commercial approval for a permanently implanted BCI for the treatment of paralysis. We are thrilled to finally be launching a U.S. clinical trial this year,” said Synchron CEO Thomas Oxley, MD, Ph.D.

Other implantable BCI approaches involve drilling into the skull and placing needle electrodes directly into the brain tissue, which can result in long-term brain inflammation. The Stentrode device is delivered into the brain via the blood vessels in a minimally invasive 2-hour procedure, similar to the insertion of stents in the heart. No robotic assistance is required for the procedure, which can be performed in widely available angiography suites. The implant is fully internalized with no wires coming out of the head or body, reports BusinessWire.

Patients begin using the device at home soon after implantation and may wirelessly control external devices by thinking about moving their limbs. The system is designed to facilitate better communication and functional independence for patients by enabling daily tasks like texting, emailing, online commerce, and accessing telemedicine.

“Synchron’s north star is to achieve whole-brain data transfer,” continued Oxley. “The blood vessels provide surgery-free access to all regions of the brain, and at scale. Our first target is the motor cortex for the treatment of paralysis, which represents a large unmet need for millions of people across the world, and a market opportunity of $20B.”

Synchron is collaborating with Carnegie Mellon University, the University of Pittsburgh Medical Center and Mount Sinai Health System, New York City, on the new study, the COMMAND trial. A total of six patients are planned for the trial, with enrollment beginning later this year.

Read more: Elon Musk Demonstrates Neuralink Brain-Computer Interface with Live Pigs

Synchron continues to evaluate the device in the SWITCH clinical trial currently underway in Australia. Four patients have received the Stentrode implant and are utilizing this neuroprosthesis for data transfer from the motor cortex to control digital devices. Data from the first two patients in this study, which were published in the Journal of NeuroInterventional Surgery (JNIS) in October 2020, demonstrated each patient was able to control their devices to text and type through direct thought. Following implantation and a short period of machine learning-assisted training, they were able to use the system unsupervised in their homes to send text messages, do online shopping and manage their finances.

Text Link

Nanomembrane Wearable Sensors Deliver Precision and Continuous Stress Monitoring

Researchers at Georgia Tech has developed SKINTRONICS – a wearable stress monitor that utilizes ...

Researchers at Georgia Tech have developed SKINTRONICS – a wearable stress monitor that utilizes fully stretchable, wireless skin-conformal bioelectronics, designed to provide precise readings of heart rate and sweat gland activity via galvanic skin response.

Read more: Ultrasound Wearable Patch Could Provide Early Warning for Heart Attacks and Strokes

Georgia Tech’s thin, conductive film and flexible layered electrodes with nanomembrane sensors create an impressive device that weighs less than 7 g, including its rechargeable battery. Other galvanic skin response wearable monitors may weigh (in volume) six times more than this technology or greater.

Where other devices lack the ability to maintain adequate contact without pressure from a band or strap, this adaptable stress monitor can be applied directly to the skin and fits snugly to the natural curvature of the body at the wrist or shoulder. The bioelectric wearable device is designed for greater comfort—it is soft, thin, and less than 5 mm thick. The durability and performance of the portable stress monitor have been tested to confirm that it can endure the daily wear of its users, reports Georgia Tech.

The quality of the data output of the high-sensitivity nanomembranes in this novel device was also tested and measured to be comparable, if not superior when concurrently compared to two commercially available devices. Georgia Tech’s portable stress monitor is designed to provide more accurate ongoing measurements and delivers an improved wearable design so that cardiac patients, infants in the pediatric intensive care unit (PICU), or even athletes may receive improved health monitoring with greater comfort.

Benefits/Advantages

  • All-in-one: The personal adhesive bandage-like single device platform offers wireless, multi-data sensing by simply mounting it on the skin.
  • Disposable: This wearable device is fully disposable after use and the measured data can be simply sent to the cloud via a tablet or smartphone app.
  • Compact: The unique, thin design of this bioelectric device is one-sixth the volume of current market offerings—weighing less than 7 g, including its rechargeable battery.
  • Greater comfort: The pattern of the biosensor’s electrodes is constructed to allow more than 50% stretchability and 30% areal coverage to the skin without the need for a constricting band or strap.
  • Durable: The device has been successfully tested for flexibility and stability of its components with 1,000 cyclic stretching experiments to mimic daily use on the skin.

Potential Commercial Applications

  • Stress monitoring for cardiac patients
  • Neo-natal monitoring in PICU
  • Pediatric patient health monitoring
  • Baseline metrics and ongoing monitoring of athletes
  • Corporate and public employee wellness programs

Read more: Janitri’s Wearable Patch Helping to Save Lives of Newborns and Mothers

Background and More Information

Stress monitors have evolved significantly from the originally wired electrodes—with limited placement near the palm/fingertips—to the wearable health monitors that multi-task as a pedometer, watch, and extension of the user’s cell phone. Though miniaturization of bioelectronics has improved the technology, the current market of monitors has been unable to break away from the combined plastic and metal frames that require a tight fit with a strap or band to conform to the body’s natural curvature at the wrist or ankle. Research shows that Georgia Tech’s wearable stress monitor brings greater comfort and flexibility without a constricting strap or band while providing accurate data about skin conductance changes, which is a quantifiable measurement of stress.

Text Link

Musculoskeletal Startup Hinge Health Launches HingeConnect to Integrate With Users’ EMRs

HingeConnect uniquely bridges the digital/in-person divide and enables real-time interventions ...

HingeConnect uniquely bridges the digital/in-person divide and enables real-time interventions by connecting Hinge Health’s Care Team across 71,000 clinical facilities

Digital musculoskeletal clinic Hinge Health launched HingeConnect to set a new standard in personalized care via seamless electronic medical record (EMR) integration, real-time interventions, and robust care coordination between digital and in-person providers.

Read more: Stryker Buys OrthoSensor and Its Knee Surgery Sensor Technology Verasense

The pandemic prompted a surge in digital care, providing Americans with greater access to convenient care. However, it also exposed a lack of coordination between in-person and digital providers, which can result in a poor participant experience, lower-quality care, and higher costs. This is especially relevant in musculoskeletal (MSK) health because ineffective care results in prolonged pain and increased costs and because 1% of plan members drive 55% of MSK costs, reports Hinge Health.

How HingeConnect works:

  • Real-time interventions. EMR data from 750,000 providers across 71,000 care sites is proactively monitored to identify opportunities to offer less-invasive care by flagging select orders, such as surgery referrals or opiate prescriptions. Our care team can then intervene in real-time with noninvasive and nonaddictive alternatives, such as digital care programs or the groundbreaking impulse therapy device, the Hinge Health Enso.
  • Personalized and coordinated care plans. Each member’s medical history is automatically compiled to inform the Hinge Health care team of issues such as injuries, pain medication use, and comorbid conditions so care plans can be personalized and carefully coordinated.
  • Integrated medical history. By securely sharing Hinge Health outcome data with members’ external care providers, the platform promotes robust care coordination with in-person providers.

“As digital care continues to grow, the opportunity and need to integrate with in-person care grows in lockstep,” said Dr. Michael Fredericson, Professor of Orthopedic Surgery at Stanford. “HingeConnect not only creates an integrated experience for members but also affords Hinge Health the unique ability to identify patients early in their course of treatment.”

“HingeConnect uniquely empowers our care team to see the whole picture and seamlessly coordinate care,” said Dr. Jeff Krauss, Hinge Health’s chief medical officer. “What makes HingeConnect even more valuable is the speed at which our care team receives information: sometimes within an hour of an order being created. Our staff physicians can immediately intervene to offer alternatives to surgery, or our doctors of physical therapy can intervene to offer alternatives to opioids.”

Read more: VHA Expanding Pain Management Program With SAM Wearable Ultrasound Patch

About Hinge Health

Hinge Health is pioneering the world’s most patient-centered Digital Musculoskeletal (MSK) Clinic. Four in five employers and 90% of health plans with a digital MSK solution have chosen Hinge Health. Hinge Health reduces MSK pain, opioid use, and surgeries by pairing advanced wearable technology with a comprehensive clinical care team, including doctors of physical therapy, physicians, board-certified health coaches, and more. Available to millions of members, Hinge Health is the #1 Digital MSK Clinic™ for health plans and employers, including Boeing, Salesforce, and US Foods.

Text Link

Dexcom Receives FDA Clearance for its Real-Time API Integration with Third-Party Apps and Devices

DexCom, the global leader in real-time continuous glucose monitoring (CGM) for people with ...

DexCom, the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced the FDA clearance of the Dexcom Partner Web APIs, enabling invited third-party developers to integrate real-time CGM data into their digital health apps and devices.

Read more: Dexcom G6 Pro CGM Offers Both Blinded And Unblinded Mode For Glucose Monitoring

“FDA clearance of our real-time APIs further solidifies Dexcom as the leader in interoperable CGM, giving Dexcom users even more choice in how they view and interact with their glucose data,” said Jake Leach, chief technology officer at Dexcom. “The new APIs will help seamlessly integrate the power of real-time Dexcom CGM data into some of the leading diabetes and digital health solutions.”

Several prominent diabetes and digital health companies have been invited to access the real-time APIs and are already in the testing and development phase, including Garmin® and Teladoc Health’s Livongo® for Diabetes, reports BusinessWire.

“Garmin welcomes the opportunity to bring Dexcom CGM data to runners, cyclists, and everyday users who rely on the technology 24/7 to proactively manage their diabetes,” said Joe Schrick, vice president of fitness at Garmin. “We are proud to be part of this integration that will allow users a secondary way to quickly and discreetly view estimated glucose levels and trends right from their smartwatch at any time.”

People with diabetes and their healthcare providers will benefit from the integration of real-time Dexcom CGM data into third-party apps and devices in a multitude of ways. For example, it will:

  • Allow users to quickly see all their therapy data in one place
  • Empower users to utilize the apps they find most beneficial for a more tailored Dexcom experience
  • Enable in-the-moment diabetes management coaching and feedback

Read more: Livongo Partners with Dexcom to Integrate Dexcom’s CGM System into their Platform

About DexCom

Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader in diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.

Text Link

13th IoT/WT Innovation World Cup Success Story – PK vitality

PKvitality – an innovative start-up brought up their unique solution to the 13 IoT/WT Innovation ...

PKvitality – an innovative start-up brought up its unique solution to the 13 IoT/WT Innovation World Cup®. PKvitality develops K’Watch Glucose, a line of next-generation trackers with the ability to analyze key physiological markers by simply testing the skin rather than analyzing blood samples.

  1. INTRODUCE YOURSELF! – HOW DID IT ALL START?

PKvitality is an advanced bio-wearable company currently working on its innovative Skin Taste® technology. This technology will allow the analysis of key physiological markers by simply “tasting” the skin rather than analyzing blood samples. It will be placed at the back of K’Watch, a smartwatch providing a painless and discrete Continuous Glucose Monitoring (CGM) device. It will enable precise and continuous monitoring of glucose levels anytime and anywhere. Using the same technology, PKvitality is also working on K’Watch Athlete, a smartwatch that will provide real-time monitoring of their lactic acid – an indicator of muscle fatigue – to significantly improve an athlete’s training and performance.

Read more: PKvitality’s K’Watch Glucose Is a Smartwatch That Provides Continuous Glucose Monitoring

We started this project in 2016 and the name of PKvitality pronounced “Pekka” in French means star in Polynesian dialect. It’s the encounter of the Tribal world, our origins, and the Stars, a journey, an adventure. PK is a journey toward the human being.

  1. WHAT ARE THE KEY MILESTONES YOU HAVE REACHED SO FAR?
  • 2016: project initiated
  • 01/2017: Consumer Electronic Show presence: 3 awards including 1 BEST OF INNOVATION in “Tech for a Better World”
  • December 2017: Laureate of Concours Innovation Numérique by BPIFrance (1 045K€)
  • October 2018: Entering pre-clinical stage (more in vitro, 1st in vivo, ex vivo, in silico)
  • October 2019: Beurer Gmbh, a major distributor of blood monitors in Germany, Italy, and Austria invests 2M€ alongside a 250K€ private investment from Beurer Managing Director
  • November 2019: PKvitality first company to be co-accelerated by Dassault Systemes and Sanofi
  • December 2019: Winner in the Medtech category of EIT Health Catapult contest, the largest European startup health contest
  • June 2020: Seed fundraising tour closed with a total of €3,4m
  • September 2020: Laureate of the Eurostars and Innov’up Leader PIA programs and the start of the research on multi-analyte monitoring solutions
  • September 2020: Laureate of the highly selective EIC Accelerator program
  • November 2020: Won the 12th edition of the Healthcare Innovation World Cup®

  1. WHAT WERE THE BIGGEST CHALLENGES YOU HAVE FACED?

The main challenge PKvitality has faced is due to the pluridisciplinary and complexity of the project. PKvitality has successfully gathered a team of medical experts, entrepreneurs, people with a consumer electronics approach, and a competent IT and engineering team. And all of these people work together to foster collective intelligence, that was a challenge.

The funding is also a major key to a startup's success. Many supports are foreseen so that startups can continue to develop, especially in public funding. One very important thing is to understand the ecosystem and the international, continental, or national grants/training/supports that can be applied to your company and the right timing to use them.

  1. WHAT IS COMING IN THE NEAR FUTURE?

We are currently preparing the first clinical trials that will happen in a couple of months on a reduced number of people.

  1. DESCRIBE YOUR EXPERIENCE IN THE INNOVATION WORLD CUP® AND BEING THE WINNER?

The Innovation World Cup® was a great experience for PKvitality and we will definitely be back in the competition next year!

Related PKvitality’s SkinTaste Sensor and Tiny Needles Measure Glucose by Painlessly Penetrating Your Skin

  1. CAN YOU SHARE WITH US YOUR THREE TIPS FOR UPCOMING START-UPS?
  • Gather concrete elements and results to show your product/prototype is on track and present them in an understandable and attractive way.
  • Build your presentation around coherent and fluid storytelling.
  • Practice practice practice… your pitch!

THANK YOU FOR THE INTERESTING INSIGHTS AND WE SHALL KEEP WATCHING YOUR NEXT BIG STEPS!

Visit PKvitality and learn more about their tracking devices that will help millions of people to improve their health or athletic performance.

Join the 13th IoT/WT Innovation World Cup®. Submit your solution free of charge. The top selected finalists will be invited to present their solution live at HANNOVER MESSE 2022.

Don´t miss your chance!

No items found.
Text Link

December 2025: Miniaturized Temperature Sensing Accuracy

AS6223 – Miniaturized temperature sensing accuracy for next-generation wearables.
Text Link

November 2025: Transforming Cancer Care with Wearables

Wearable implant delivering continuous, personalized cancer therapy for everyday life.
Text Link

October 2025: The New Era of Meta Smart Glasses

Meta Smart Glasses 2025: Sleek, AI-powered eyewear for hands-free capture and connection.
Text Link

September 2025: Innovation in Oxygen Monitoring

OxiWear - Innovation in wearable health, protecting you from silent hypoxia every day.
Text Link

August 2025: Ultra-Thin Battery Revolution in Wearables

NGK's 0.45mm EnerCera Battery: Non-Swelling, Non-Flammable Power for Wearables
Text Link

July 2025: Mudra Link - Neural Gesture Control Wristband

Touchless neural wristband for seamless gesture control across devices and platforms.
Text Link

June 2025: Biobeat’s Next-Generation Wearable Solution

AI-powered wearable for continuous, cuffless vital sign monitoring in clinical and home settings.
Text Link

May 2025: Breakthrough in Continuous Glucose Monitoring

Needle-free biosensor patch for real-time glucose monitoring and metabolic health insights.
Text Link

April 2025: Robeauté’s Brain Microrobot

Robeauté's microrobot enables precise, minimally invasive brain intervention with cutting-edge tech.
Text Link

March 2025: The Future of Cognitive Health

G.Brain boosts focus and brain health with AI-powered neurotechnology.
Text Link

February 2025: Revolutionizing Women's Health

Nettle™ by Samphire Neuroscience: A non-invasive, drug-free solution for women's health.
Text Link

January 2025: The Future of Heated Apparel

Revolutionizing heated clothing with sensor-driven, real-time temperature control.
Text Link

December 2024: Remote Health with Smart Patches

Wearable tech enables non-invasive, continuous health monitoring, transforming patient care.
Text Link

November 2024: Bearmind Launches Brain Health Wearable

Bearmind’s helmet sensor tracks head impacts in real time, advancing safety in contact sports.
Text Link

October 2024: Ambiq Empowers Digital Health with Edge AI

Ambiq’s low-power chips enable personal AI on-device for digital health and remote monitoring.
Text Link

September 2024: The Revolutionary .lumen Glasses

Empowering the visually impaired with smart, award-winning technology for greater independence.
Text Link

August 2024: Breakthrough in the Field of Health Monitoring

BioButton: award-winning sensor for continuous vital health monitoring with advanced AI technology.
Text Link

July 2024: Innovation in the Fight Against Voice Disorders

Speaking without vocal cords, thanks to a new AI-assisted wearable device.
Text Link

June 2024: World's Most Accurate Hydration Sensor

To prevent cramps and collapses, the company FLOWBIO has launched its hydration sensor S1.
Text Link

May 2024: Innovation in the Fight Against Hearing Loss

Neosensory's Clarify - A breakthrough solution to improve hearing.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.